Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
PaperCitations, authors & open-access status
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 778 citations, 2018 year and closed oa status.
778
Citations
2018
Year
closed
OA Status